YIH
AVXL icon

Y-Intercept (HK)’s Anavex Life Sciences AVXL Stock Holding History

Y-Intercept (HK)’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-22,631
Closed -$243K – 1191
2024
Q4 		$243K Buy
+22,631
New +$174K 0.02% 999
2024
Q3 		– Sell
-94,578
Closed -$399K – 1305
2024
Q2 		$399K Buy
+94,578
New +$383K 0.02% 912

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $2B AUM 34.81% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Y-Intercept (HK)'s AVXL Position: Q1 2025 in Review

Y-Intercept (HK) sold out of Anavex Life Sciences (AVXL) in Q1 2025, closing a stake of 22,631 shares — an estimated $243K sold.

Y-Intercept (HK) first reported a position in AVXL in Q2 2024 and held it in 2 quarters. The position peaked at $399K in Q2 2024. 181 funds tracked by Wall St. Rank hold AVXL as of Q1 2025.

  • Y-Intercept (HK) reported no remaining Anavex Life Sciences position as of Q1 2025 after selling out during the quarter.
  • Y-Intercept (HK) sold 22,631 Anavex Life Sciences shares in Q1 2025, an estimated $243K.
  • Y-Intercept (HK) first reported a position in Anavex Life Sciences in Q2 2024 and held it in 2 quarters.
  • Y-Intercept (HK)'s Anavex Life Sciences position peaked at $399K in Q2 2024.
  • 181 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2025.

Based on Y-Intercept (HK)'s 13F filing for Q1 2025, filed 6 May 2025.